Superworth

AtriCure PE ratio ATRC

Share price divided by earnings per share over the last twelve months, since 2021.

Today, Nov 2, 2026
285×
5-year median
61.7×
Against its 5-year history
97th
percentile: 0 is its lowest day, 100 its highest
5-year range
28.9× to 292×
Peer median
34.1×

AtriCure's PE ratio is 285× as of Nov 2, 2026: a share price of $59.88 against $0.21 of earnings per share over the last twelve months.

That is above its 5-year median of 61.7×, higher than on 97% of days in the last 5 years.

Over that time it ranged from 28.9× in Oct 2022 to 292× in Oct 2026.

The median for 10 medical instruments and supplies stocks of a similar size is 34.1×.

PE ratio over time

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far285×180×292×
2025n/m a value too high to mean anything
2024n/m a value too high to mean anything
2023n/m a value too high to mean anything
202236.1×28.9×68.9×
202173.2×68.6×91.7×

Against its peers

Companies in Medical - Instruments & Supplies nearest AtriCure's size, closest first, today.

Where AtriCure ranks

What the PE ratio tells you

Share price divided by earnings per share over the last twelve months. It is the price tag on a dollar of profit: 20× means you pay $20 for $1 of yearly earnings.

Blank while earnings are negative. A very low PE can mean the market expects profits to fall, so read it with growth and the company's own history.

More on AtriCure

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.